{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T12:51:24Z","timestamp":1697374284794},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,11,22]],"date-time":"2008-11-22T00:00:00Z","timestamp":1227312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00277-008-0640-3","type":"journal-article","created":{"date-parts":[[2008,11,21]],"date-time":"2008-11-21T13:38:40Z","timestamp":1227274720000},"page":"699-700","source":"Crossref","is-referenced-by-count":11,"title":["Clinical efficacy of vorinostat in a patient with essential thrombocytosis and subsequent myelofibrosis"],"prefix":"10.1007","volume":"88","author":[{"given":"Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,22]]},"reference":[{"key":"640_CR1","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1182\/blood.V106.11.2801.2801","volume":"106","author":"G Garcia-Manero","year":"2005","unstructured":"Garcia-Manero G, Yang H, Sanchez-Gonzalez B et al (2005) Final results of a phase I study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with leukemia and myelodysplastic syndrome. Blood 106:2801. doi: 10.1182\/blood-2005-05-1933","journal-title":"Blood"},{"key":"640_CR2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00277-005-1104-7","volume":"84","author":"Y Inoue","year":"2005","unstructured":"Inoue Y, Suzuki T, Takimoto M et al (2005) Treatment with valproic acid for myelofibrosis with myeloid metaplasia. Ann Hematol 84:833\u2013834. doi: 10.1007\/s00277-005-1104-7","journal-title":"Ann Hematol"},{"key":"640_CR3","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2006.10.2434","volume":"25","author":"EA Olsen","year":"2007","unstructured":"Olsen EA, Kim YH, Kuzel TM et al (2007) Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma. J Clin Oncol 25:3109\u20133115. doi: 10.1200\/JCO.2006.10.2434","journal-title":"J Clin Oncol"},{"key":"640_CR4","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1158\/0008-5472.CAN-07-0572","volume":"67","author":"J Shi","year":"2007","unstructured":"Shi J, Zhao Y, Ishii T et al (2007) Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis. Cancer Res 67:6417\u20136424. doi: 10.1158\/0008-5472.CAN-07-0572","journal-title":"Cancer Res"},{"key":"640_CR5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4065\/79.7.857","volume":"79","author":"RT Silver","year":"2004","unstructured":"Silver RT (2004) Myelofibrosis: thalidomide finds a new disease. Mayo Clin Proc 79:857\u2013858","journal-title":"Mayo Clin Proc"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0640-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-008-0640-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0640-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T16:27:35Z","timestamp":1589128055000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-008-0640-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,22]]},"references-count":5,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["640"],"URL":"https:\/\/doi.org\/10.1007\/s00277-008-0640-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,22]]}}}